Crystal Watson - Concepedia

Author

Crystal Watson

Amgen (United States)

Also Known As

, Amy Webster, C Watson, C. L. WATSON, C. Watson, Crystal Watson, Watson, Crystal

110

Publications

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Biogen (United States)Strategic Solutions Consulting (United States)Truven Health Analytics (United States)Thomson Reuters (United States)

About

Crystal Watson is an author at Amgen (United States) specializing in medicine, patient safety, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	190
2	Health Sciences	2	2	76
3	Health Policy	2	2	80
4	Public Health	1	1	36
5	Emergency Medicine	1	1	18

Crystal Watson

Publications

917

Citations

H-Index

Page 1

	Year	Citations
Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke Barbara H. Johnson, Machaon Bonafede, Crystal Watson ClinicoEconomics and Outcomes Research	2016	144
Treatment Patterns in the First Year After Initiating Tumor Necrosis Factor Blockers in Real-World Settings Machaon Bonafede, Kathleen M. Fox, Crystal Watson, Advances in Therapy	2012	90
Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US survey H.J. Gross, Crystal Watson Neuropsychiatric Disease and Treatment	2017	74
Costs of Tumor Necrosis Factor Blockers Per Treated Patient Using Real-World Drug Data in a Managed Care Population Vernon F. Schabert, Crystal Watson, George J Joseph, Journal of Managed Care Pharmacy	2013	63
Cost per Treated Patient for Etanercept, Adalimumab, and Infliximab Across Adult Indications: a Claims Analysis Machaon Bonafede, Shravanthi R. Gandra, Crystal Watson, Advances in Therapy Healthcare ValueHealth EconomicsHealth PolicyClinical TrialsOutcomes Research	2012	58
Mean lifetime survival estimates following solid organ transplantation in the US and UK Christopher N. Graham, Crystal Watson, Arie Barlev, Journal of Medical Economics	2022	50
Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States Vernon F. Schabert, Crystal Watson, Shravanthi R. Gandra, Journal of Medical Economics	2011	49
Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting Machaon Bonafede, Barbara H. Johnson, Kathleen M. Fox, Journal of Dermatological Treatment	2013	47
Treatment Patterns in Disease-Modifying Therapy for Patients With Multiple Sclerosis in the United States Machaon Bonafede, Barbara H. Johnson, Madé Wenten, Clinical Therapeutics Medical TreatmentNeurological DisorderTreatment OptionRehabilitationNeurology	2013	36
Dosing patterns of three tumor necrosis factor blockers among patients with rheumatoid arthritis in a large United States managed care population Maxine D. Fisher, Crystal Watson, Kathleen M. Fox, Current Medical Research and Opinion	2013	34

Page 1